Literature DB >> 22622175

Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.

Nora Hagelberg1, Sargo Aalto, Lauri Tuominen, Ullamari Pesonen, Kjell Någren, Jarmo Hietala, Harry Scheinin, Antti Pertovaara, Ilkka K Martikainen.   

Abstract

Previous PET studies in healthy humans have shown that brain μ-opioid receptor activation during experimental pain is associated with reductions in the sensory and affective ratings of the individual pain experience. The aim of this study was to find out whether brain μ-opioid receptor binding at the resting state, in absence of painful stimulation, can be a long-term predictor of experimental pain sensitivity. We measured μ-opioid receptor binding potential (BP(ND)) with μ-opioid receptor selective radiotracer [(11)C]carfentanil and positron emission tomography (PET) in 12 healthy male subjects. Later, we recruited these subjects to participate in a separate psychophysical testing session to measure cold pressor pain threshold, cold pressor pain tolerance and tactile sensitivity with von Frey monofilaments. We used both voxel-by-voxel and region-of-interest image analyses to examine the potential associations between μ-opioid receptor BP(ND) and psychophysical measures. The results show that striatal μ-opioid receptor BP(ND) predicts cold pressor pain threshold, but not cold pressor pain tolerance or tactile sensitivity. This finding suggests that striatal μ-opioid receptor density is involved in setting individual pain threshold.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622175     DOI: 10.1016/j.neulet.2012.05.042

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.

Authors:  Tomi Karjalainen; Lauri Tuominen; Sandra Manninen; Kari K Kalliokoski; Pirjo Nuutila; Iiro P Jääskeläinen; Riitta Hari; Mikko Sams; Lauri Nummenmaa
Journal:  Soc Cogn Affect Neurosci       Date:  2016-04-06       Impact factor: 3.436

2.  Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjects.

Authors:  Jussi Lehto; Jarkko Johansson; Lauri Vuorilehto; Pauliina Luoto; Eveliina Arponen; Harry Scheinin; Juha Rouru; Mika Scheinin
Journal:  Psychopharmacology (Berl)       Date:  2015-04-29       Impact factor: 4.530

3.  Ethnic disparities in pain processing among healthy adults: μ-opioid receptor binding potential as a putative mechanism.

Authors:  Janelle E Letzen; Chung Jung Mun; Hiroto Kuwabara; Emily F Burton; Brandon L Boring; Taylor Walls; Traci J Speed; Dean F Wong; Claudia M Campbell
Journal:  Pain       Date:  2020-04       Impact factor: 7.926

Review 4.  Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

Authors:  Matthieu Colom; Benjamin Vidal; Luc Zimmer
Journal:  Front Mol Neurosci       Date:  2019-10-18       Impact factor: 5.639

5.  μ-opioid receptor availability is associated with sex drive in human males.

Authors:  Lauri Nummenmaa; Patrick Jern; Tuulia Malén; Tatu Kantonen; Laura Pekkarinen; Lasse Lukkarinen; Lihua Sun; Pirjo Nuutila; Vesa Putkinen
Journal:  Cogn Affect Behav Neurosci       Date:  2021-11-22       Impact factor: 3.282

6.  Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.

Authors:  Andrew Schrepf; Daniel E Harper; Steven E Harte; Heng Wang; Eric Ichesco; Johnson P Hampson; Jon-Kar Zubieta; Daniel J Clauw; Richard E Harris
Journal:  Pain       Date:  2016-10       Impact factor: 7.926

Review 7.  A Survey of Molecular Imaging of Opioid Receptors.

Authors:  Paul Cumming; János Marton; Tuomas O Lilius; Dag Erlend Olberg; Axel Rominger
Journal:  Molecules       Date:  2019-11-19       Impact factor: 4.411

8.  Laughter influences social bonding but not prosocial generosity to friends and strangers.

Authors:  R I M Dunbar; Anna Frangou; Felix Grainger; Eiluned Pearce
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.